This study reports the absolute oral bioavailability and mammary excretion
of bisphenol A in rats. The oral bioavailability was determined after admin
istration of relatively low iv (0.1 mg/kg) and oral (10 mg/kg) doses of bis
phenol A to rats. After iv injection, serum levels of bisphenol A declined
biexponentially, with the mean initial distribution and terminal eliminatio
n half-lives being 6.1 +/- 1.3 min and 52.5 +/- 2.4 min, respectively. The
systemic clearance (Cl-s) and the steady-state volume of distribution (V-ss
) averaged 107.9 +/- 28.7 ml/min/kg and 5.6 +/- 2.4 L/kg, respectively. Upo
n oral administration, the maximum serum concentration (C-max) and the time
to reach the maximum concentration (T-max) were 14.7 +/- 10.9 ng/ml and 0.
2 +/- 0.2 h, respectively. The apparent terminal elimination half-life of b
isphenol A (21.3 +/- 7.4 h) after oral administration was significantly lon
ger than that after iv injection, indicating the flip-flop of the absorptio
n and elimination rates. The absolute oral bioavailability of bisphenol A w
as low (5.3 +/- 2.1%). To determine the extent of mammary excretion, bisphe
nol A was given by simultaneous iv bolus injection plus infusion to steady
state at low, medium, and high doses. The steady-state serum levels of bisp
henol A were linearly increased with higher dosing rates. The systemic clea
rance (mean range, 119.2-154.1 ml/min/kg) remained unaltered over the dosin
g rate studied. The levels of bisphenol A in milk exceeded those in serum,
with the steady-state milk to serum concentration ratio being 2.4-2.7.